Persistent GB Virus C Infection and Survival in HIV-Infected Men

New England Journal of Medicine

Volumn 350, Issue 10, 2004, Pages 981-990

  Williams, Carolyn F ^a   Klinzman, Donna ^b   Yamashita, Traci E ^c   Xiang, Jinhua ^b   Polgreen, Philip M ^b   Rinaldo, Charles ^d   Liu, Chenglong ^e   Phair, John ^f   Margolick, Joseph B ^c   Zdunek, Dietmar ^g   Hess, Georg ^g   Stapleton, Jack T ^b,h  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g ROCHE DIAGNOSTICS GMBH   (Germany)

^h UNIVERSITY OF IOWA HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; VIRUS RNA;

ARTICLE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SURVIVAL; T LYMPHOCYTE; VIREMIA; VIRUS REPLICATION;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; PROGNOSIS; RNA, VIRAL; SURVIVAL RATE; VIREMIA;

EID: 10744229112     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa030107     Document Type: Article

References (36)

1. Rowland-Jones S. Long-term non-progression in HIV infection: clinico pathological issues. J Infect 1999;38:67-70.
2. Buchbinder S, Vittinghoff E. HIV-infected long-term nonprogressors: epidemiology, mechanisms of delayed progression, and clinical and research implications. Microbes Infect 1999;1:1113-20.
3. Heringlake S, Ockenga J, Tillmann HL, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998;177:1723-6.
4. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:209-13.
5. Lefrère JJ, Roudot-Thoraval F, Morand-Joubert L, et al. Carriage of GB virus C/hepa titis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179:783-9.
6. Yeo AET, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia: Multicenter Hemophilia Cohort Study. Ann Intern Med 2000;132:959-63.
7. Xiang J, Wünschmann S, Diekema DJ, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001;345:707-14.
8. Tillmann HL, Heiken H, Knapik-Botor A, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001;345:715-24.
9. Stapleton JT. GB virus type C/hepatitis G virus. Semin Liver Dis 2003;23:137-48.
10. Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997;37:569-72.
11. Fischler B, Lara C, Chen M, Sonnerborg A, Nemeth A, Sallberg M. Genetic evidence for mother-to-infant transmission of hepatitis G virus. J Infect Dis 1997;176:281-5.
12. Linnen J, Wages J Jr, Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
13. Dawson GJ, Schlauder GG, Pilot-Matias TJ, et al. Prevalence studies of GB virus-C using reverse transcriptase-polymerase chain reaction. J Med Virol 1996;50:97-103.
14. Semprini AE, Persico T, Thiers V, et al. Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men. J Infect Dis 1998;177:848-54.
15. Rubio A, Rey C, Sanchez-Quijano A, et al. Is hepatitis G virus transmitted sexually? JAMA 1997;277:532-3.
16. Wu JC, Sheng WY, Huang YH, Hwang SJ, Lee SD. Prevalence and risk factor analysis of GBV-C/HGV infection in prostitutes. J Med Virol 1997;52:83-5.
17. Feucht H-H, Zollner B, Polywka S, Laufs R. Vertical transmission of hepatitis G. Lancet 1996;347:615-6.
18. Toyoda H, Takahashi I, Fukuda Y, Hayakawa K, Takamatsu J. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia. J Med Virol 2000;60:34-8.
19. Tacke M, Schmolke S, Schlueter V, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with longterm recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997;26:1626-33.
20. Thomas DL, Vlahov D, Alter HJ, Marshall R, Astemborski J, Nelson KE. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from re-infection. J Infect Dis 1998;177:539-42.
21. Xiang J, Wunschmann S, Schmidt WN, Shao J, Stapleton JT. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 2000;74:9125-33.
22. Sabin CA, Devereux H, Kinson Z, et al. Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men. J Acquir Immun Defic Syndr Hum Retrovirol 1998;19:546-8.
23. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002;16:2482-5.
24. Brust D, Jagannatha S, Herpin B, et al. Hepatitis G virus (HGV) infection does not prolong survival of patients with early-stage HIV disease: importance of baseline HIV viral load as a predictor of mortality. In: Abstracts of the 14th International AIDS Conference, Barcelona, Spain, July 7-12, 2002. abstract.
25. Mosier DE, Chisari FV. GB virus C and mortality from HIV infection. N Engl J Med 2002;346:377.
26. Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, Brookmeyer R. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol 1987;126:568-77.
27. Kaslow RA, Ostrow DG, Detels P, Phair J, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
28. Dudley J, Jin S, Hoover D, Metz S, Thackeray R, Chmiel J. The Multicenter AIDS Cohort Study: retention after 9 1/2 112 years. Am J Epidemiol 1995;142:525-30.
29. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
30. Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA 1998;280:1497-503.
31. Xiang J, Klinzman D, McLinden J, et al. Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 1998;72:2738-44.
32. Stapleton JT, Klinzman D, Schmidt WN, et al. Prospective comparison of wholeblood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA. J Clin Microbiol 1999;37:484-9.
33. Ioannidis JP, Rosenberg PS, Goedert JJ, et al. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: an international meta-analysis of individual-patient data. Ann Intern Med 2001;135:782-95.
34. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-62. [Erratum, Science 1996;274:1069.]
35. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene: Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-62. [Erratum, Science 1996;274:1069.]
36. Klinzman D, Katz L, George SL, et al. GB virus C/hepatitis G virus: does clearance of viremia differ based on mode of transmission? In: Viral hepatitis and liver disease. Atlanta: International Medical Press (in press).